Effect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and Stability

被引:36
|
作者
Ebersole, Brittany [1 ]
Petko, Jessica [1 ]
Woll, Matthew [1 ]
Murakami, Shoko [2 ]
Sokolina, Kate [3 ]
Wong, Victoria [3 ,4 ]
Stagljar, Igor [3 ,4 ]
Luescher, Bernhard [2 ,5 ,6 ]
Levenson, Robert [1 ]
机构
[1] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA
[2] Penn State Univ, Dept Biol, University Pk, PA 16802 USA
[3] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[4] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[5] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA
[6] Penn State Univ, Ctr Mol Invest Neurol Disorders, University Pk, PA 16802 USA
来源
PLOS ONE | 2015年 / 10卷 / 11期
基金
美国国家卫生研究院;
关键词
22Q11 DELETION SYNDROME; PROTEIN PALMITOYLATION; DIFFERENTIAL REGULATION; GABA(A) RECEPTORS; MAMMALIAN-CELLS; FATTY-ACYLATION; SPLIT-UBIQUITIN; MOUSE MODEL; SCHIZOPHRENIA; LOCALIZATION;
D O I
10.1371/journal.pone.0140661
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have used bioorthogonal click chemistry (BCC), a sensitive non-isotopic labeling method, to analyze the palmitoylation status of the D2 dopamine receptor (D2R), a G protein-coupled receptor (GPCR) crucial for regulation of processes such as mood, reward, and motor control. By analyzing a series of D2R constructs containing mutations in cysteine residues, we found that palmitoylation of the D2R most likely occurs on the C-terminal cysteine residue (C443) of the polypeptide. D2Rs in which C443 was deleted showed significantly reduced palmitoylation levels, plasma membrane expression, and protein stability compared to wild-type D2Rs. Rather, the C443 deletion mutant appeared to accumulate in the Golgi, indicating that palmitoylation of the D2R is important for cell surface expression of the receptor. Using the full-length D2R as bait in a membrane yeast two-hybrid (MYTH) screen, we identified the palmitoyl acyltransferase (PAT) zDHHC4 as a D2R interacting protein. Co-immunoprecipitation analysis revealed that several other PATs, including zDHHC3 and zDHHC8, also interacted with the D2R and that each of the three PATs was capable of affecting the palmitoylation status of the D2R. Finally, biochemical analyses using D2R mutants and the palmitoylation blocker, 2-bromopalmitate indicate that palmitoylation of the receptor plays a role in stability of the D2R.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization
    Wouters, Elise
    Ricarte Marin, Adrian
    Rupert Dalton, James Andrew
    Giraldo, Jesus
    Stove, Christophe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [22] The dopamine D2 receptor 5′-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo
    Pohjalainen, T
    Någren, K
    Syvälahti, EKG
    Hietala, J
    PHARMACOGENETICS, 1999, 9 (04): : 505 - 509
  • [23] DOPAMINE D2 RECEPTOR BLOCKING EFFECT OF IMIPRAMINE IN THE RAT HIPPOCAMPUS
    SMIALOWSKI, A
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (01) : 105 - 108
  • [24] The effect of paraquat on the expression of D2 dopamine receptor in CAD cells
    Kim, Ok-Jin J.
    Megaris, Michael Paul
    Azadani, Zahra Crystal
    FASEB JOURNAL, 2008, 22
  • [25] Cortical dopamine D2 receptor dysfunction in Huntington's disease
    Pavese, N
    Rosser, AE
    Brooks, DJ
    Barker, RA
    Dunnett, SB
    Piccini, P
    MOVEMENT DISORDERS, 2002, 17 : S318 - S318
  • [26] Dopamine D2 receptor TaqI a polymorphism and Parkinson's disease
    Zappia, M
    Annesi, G
    Quattrone, A
    MOVEMENT DISORDERS, 2001, 16 (05) : 975 - 975
  • [27] Dopamine D4 receptor counteracts dopamine D2 receptor effect through different PKC isoenzymes
    Chang, HT
    Chu, PL
    Wu, V
    Wu, KD
    Hseih, BS
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 229A - 229A
  • [28] Effect of age on extrastriatal dopamine D2 receptor availability.
    Wang, GJ
    Volkow, ND
    Fowler, JS
    Logan, J
    Pappas, N
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1255 - 1255
  • [29] Bifeprunox:: Dopamine D2 receptor occupancy
    Devries, M
    Grahnen, A
    Bergström, M
    Långström, B
    Olsen, CK
    Brennum, LT
    Kreilgaard, M
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 243S - 244S
  • [30] ASPECTS OF THE STRUCTURE OF THE D2 DOPAMINE RECEPTOR
    STRANGE, PG
    TRENDS IN NEUROSCIENCES, 1990, 13 (09) : 373 - 378